{"entity":{"id":"nct06107686","kind":"trial","name":"A Study of YL202 in Selected Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 2 trial of YL202 should be intravenously infused in non-small-cell lung cancer, run by MediLink Therapeutics (Suzhou) Co., Ltd., now recruiting.","summary":"A Study of YL202 in Selected Patients With Advanced Solid Tumors is a phase 2 interventional study registered as NCT06107686 by MediLink Therapeutics (Suzhou) Co., Ltd., with 200 participants planned, started 2023-12-15 and due to reach its primary completion in 2026-11. Interventions recorded: YL202 should be intravenously infused.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06107686","url":"https://clinicaltrials.gov/study/NCT06107686"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":["yl202"],"companies":["medilink"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06107686","phase":"2","setting":"A Multicenter, Open-Label, Phase II Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of YL202 in Selected Patients With Advanced Solid Tumors","sponsor":"MediLink Therapeutics (Suzhou) Co., Ltd.","participation":[{"nct":"NCT06107686","source":"https://clinicaltrials.gov/study/NCT06107686","fetchedAt":"2026-10-07T16:54:11.803Z","studySha256":"fc5325e4457d3c9f679d2a407909ed91317f0e5f0fadc7bd85e72419a6439436","overallStatus":"RECRUITING","lastUpdatePosted":"2025-11-26","leadSponsor":"MediLink Therapeutics (Suzhou) Co., Ltd.","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"75 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":200,"enrolmentType":"ESTIMATED","siteCount":82,"recruitingSiteCount":48,"countries":["China"]}],"started":"2023-12-15","startedType":"actual","enrolled":200,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06107686/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"drug":[{"id":"yl202","kind":"drug","name":"YL202","route":"/drugs/yl202/"}],"company":[{"id":"medilink","kind":"company","name":"MediLink Therapeutics","route":"/companies/medilink/"}]}}